This lecture will explore how methadone dispensing practices across U.S. opioid treatment programs (OTPs) changed following the COVID-19 regulatory relaxation that expanded eligibility for take-home doses. Using data from a multi-state retrospective chart review, we will examine daily methadone treatment trajectories before and after the policy change, highlighting key drivers of variation, including clinic-level practices and patient characteristics such as methamphetamine use, housing status, and gender. The session will emphasize how institutional decision-making, more than individual clinical factors, shaped access to take-home medication and discuss the implications for equitable and evidence-based care moving forward.
Continuing Medical Education (CME) Credits Available
Participants in this program may earn the following CME credits:
✔ 1 AOA Category 1-A Credit
Earn valuable continuing education credits while enhancing your professional knowledge!